Genomic Tumor Board
A Genomic tumor board (GTB) consists of a team of multidisciplinary healthcare professionals who collaborate to review genomic tumor tests (GTT). These boards function to analyze results of GTTs to help guide potential treatment decisions using the latest research. The goal of these sessions is to work together to provide interpretation support for clinicians and engage community oncologists in a robust discussion of treatment options for the patient and evaluate actionable results.